Get 20% lifetime commission for referring investors to digrin.com
here.
Unicycive Therapeutics, Inc. ( UNCY) - Key Metrics
UNCY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.06 | -$0.28 | -$0.28 |
| 2026Q1 | $0 | -$0.54 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.74 | -$0.40 | -$0.40 |
| 2025Q3 | $0 | -$0.33 | -$0.33 | -$0.33 |
| 2025Q2 | $0 | -$0.52 | -$0.68 | -$0.68 |
UNCY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -18.32 |
| 2026Q1 | 0% | -3.05 |
| 2025Q4 | 0% | -1.95 |
| 2025Q3 | 0% | -3.30 |
| 2025Q2 | 0% | -2.29 |
UNCY
Price: $5.62
52 week price:
Earnings Per Share: -1.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23619
Market Capitalization: 150.9 million